Avio Smart Market Stack, in collaboration with Huwel Lifesciences, has announced the launch of patented molecular diagnostic products across multiple healthcare segments. The initiative aims to revolutionize diagnostics in India by offering advanced, affordable, and scalable solutions, strengthening early disease detection and supporting the country’s growing healthcare infrastructure.
Avio Smart Market Stack has partnered with Huwel Lifesciences, a leading biotech innovator, to introduce a new range of patented molecular diagnostic products designed to transform healthcare delivery in India. These solutions will cater to diverse segments including infectious diseases, oncology, genetic disorders, and preventive health screening.
The collaboration leverages Huwel’s proprietary molecular technologies alongside Avio’s market expertise to ensure wider accessibility and affordability. Industry experts highlight that molecular diagnostics are critical for early detection, precision medicine, and improved patient outcomes, especially in a country with rising demand for advanced healthcare solutions.
This launch is expected to accelerate India’s adoption of cutting-edge diagnostic tools, reduce dependency on imports, and strengthen domestic biotech innovation. The products will be rolled out across hospitals, diagnostic labs, and specialized healthcare centers in phases.
Key Highlights
-
Partnership: Avio Smart Market Stack & Huwel Lifesciences.
-
Innovation: Patented molecular diagnostic products.
-
Healthcare Segments: Infectious diseases, oncology, genetic disorders, preventive screening.
-
Impact: Affordable, scalable, and accessible diagnostics for India.
-
Strategic Goal: Strengthen domestic biotech ecosystem and reduce import reliance.
-
Rollout: Phased introduction across hospitals and diagnostic labs.
Sources: Business Standard, Economic Times, PharmaBiz